Danaher Corporation $DHR Stake Boosted by Shell Asset Management Co.

Key Points

• Shell Asset Management Co. increased its stake in Danaher Corporation by 16.7%, owning 35,550 shares valued at approximately $7 million.
• Danaher announced a quarterly dividend of $0.32 per share, with an annualized yield of 0.6%, to be paid on October 31st.
• Wall Street analysts have mixed projections for Danaher, with 17 analysts rating it as a Buy while four maintain a Hold rating, and an average target price of $245.91.

Shell Asset Management Co. raised its position in shares of Danaher Corporation (NYSE:DHR - Free Report) by 16.7% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 35,550 shares of the conglomerate's stock after buying an additional 5,087 shares during the quarter. Shell Asset Management Co.'s holdings in Danaher were worth $7,023,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in DHR. GHP Investment Advisors Inc. lifted its position in shares of Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after acquiring an additional 99 shares in the last quarter. Sierra Ocean LLC lifted its holdings in shares of Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after purchasing an additional 76 shares in the last quarter. Red Tortoise LLC lifted its holdings in shares of Danaher by 175.0% in the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate's stock valued at $30,000 after purchasing an additional 98 shares in the last quarter. Smallwood Wealth Investment Management LLC acquired a new stake in shares of Danaher in the first quarter worth $31,000. Finally, Dunhill Financial LLC grew its holdings in shares of Danaher by 68.4% during the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock valued at $34,000 after buying an additional 67 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on DHR. Wells Fargo & Company reduced their price objective on Danaher from $210.00 to $205.00 and set an "equal weight" rating for the company in a research note on Wednesday, July 23rd. Bank of America dropped their target price on Danaher from $230.00 to $220.00 and set a "buy" rating on the stock in a report on Monday, September 22nd. Barclays restated an "overweight" rating and set a $225.00 price target (up from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Scotiabank upgraded shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price objective on the stock in a research note on Friday, July 11th. Finally, Weiss Ratings reiterated a "hold (c-)" rating on shares of Danaher in a research report on Saturday, September 27th. Seventeen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $245.91.

Danaher Stock Down 1.6%

DHR stock opened at $211.65 on Tuesday. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The firm has a market cap of $151.55 billion, a PE ratio of 45.03, a PEG ratio of 3.06 and a beta of 0.77. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $279.41. The company has a fifty day simple moving average of $200.36 and a 200 day simple moving average of $197.24.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. The company had revenue of $5.94 billion during the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business's quarterly revenue was up 3.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Sell-side analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher's dividend payout ratio (DPR) is 27.23%.

Insider Activity at Danaher

In other news, Director Teri List sold 2,778 shares of the business's stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 11.10% of the stock is currently owned by corporate insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.